Publicacións (38) Publicacións nas que participase algún/ha investigador/a

2010

  1. A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling

    Stem Cell Reviews and Reports, Vol. 6, Núm. 2, pp. 162-177

  2. A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541

  3. Abdomen agudo e ingesta de cuerpos extraños: revisión de seis casos

    Galicia Clínica, Vol. 71, Núm. 3, pp. 117-120

  4. Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357

  5. Adjuvant docetaxel for high-risk, node-negative breast cancer

    New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210

  6. Adult stem cells and their relationship with cancer

    Cancer and Chemotherapy Reviews, Vol. 5, Núm. 2, pp. 75-81

  7. Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 3, pp. 567-573

  8. Artropatía neuropática del hombro por siringomielia

    Medicina Clinica, Vol. 135, Núm. 1, pp. 45

  9. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing Spondylitis

    Arthritis and Rheumatism, Vol. 62, Núm. 4, pp. 1000-1006

  10. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

    British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473

  11. Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

    Chemotherapy, Vol. 56, Núm. 2, pp. 142-146

  12. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  13. Current controversies in the management of breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286

  14. Cáncer de ovario. Enfermedad platino resistente

    Revisiones en Cancer, Vol. 24, Núm. 6, pp. 253-262

  15. Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

    Journal of Translational Medicine, Vol. 8

  16. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection

    Journal of Virology, Vol. 84, Núm. 1, pp. 475-481

  17. Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy

    Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848

  18. Enfermedad de Rendu-Osler con afectación hepática: primer trasplante en España

    Medicina Clinica, Vol. 135, Núm. 12, pp. 552-555

  19. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias

    Experimental and Molecular Pathology, Vol. 89, Núm. 2, pp. 197-203

  20. Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients

    Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440